Literature DB >> 17485887

Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for Japanese.

Tamio Teramoto1, Jun Sasaki, Hirotsugu Ueshima, Genshi Egusa, Makoto Kinoshita, Kazuaki Shimamoto, Hiroyuki Daida, Sadatoshi Biro, Kazuhiko Hirobe, Tohru Funahashi, Kotaro Yokote, Masayuki Yokode.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17485887     DOI： 10.5551/jat.14.45

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN： 1340-3478            Impact factor:   4.928


× No keyword cloud information.
  47 in total

1.  Characteristics of plaque progression detected by serial coronary computed tomography angiography.

Authors:  Hajime Ito; Sadako Motoyama; Masayoshi Sarai; Hideki Kawai; Hiroto Harigaya; Shino Kan; Shigeru Kato; Hirofumi Anno; Hiroshi Takahashi; Hiroyuki Naruse; Junichi Ishii; Jagat Narula; Yukio Ozaki
Journal:  Heart Vessels       Date:  2013-10-11       Impact factor: 2.037

2.  ApoE isoforms, treatment of diabetes and the risk of coronary heart disease.

Authors:  Hideki Ehara; Ritsuko Yamamoto-Honda; Hiroji Kitazato; Yoshihiko Takahashi; Shoji Kawazu; Yasuo Akanuma; Mitsuhiko Noda
Journal:  World J Diabetes       Date:  2012-03-15

3.  P-wave morphologic characteristics predict cardiovascular events in a community-dwelling population.

Authors:  Tomoyuki Kabutoya; Shizukiyo Ishikawa; Joji Ishikawa; Satoshi Hoshide; Kazuomi Kario
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-07       Impact factor: 1.468

4.  Risk of New-Onset Dyslipidemia After Laparoscopic Adrenalectomy in Patients with Primary Aldosteronism.

Authors:  Mayuko Kaga; Takanobu Utsumi; Tomoaki Tanaka; Takashi Kono; Hidekazu Nagano; Koji Kawamura; Naoto Kamiya; Takashi Imamoto; Naoki Nihei; Yukio Naya; Hiroyoshi Suzuki; Tomohiko Ichikawa
Journal:  World J Surg       Date:  2015-12       Impact factor: 3.352

5.  Prevalence of dyslipidemia in Japanese patients with rheumatoid arthritis and effects of atorvastatin treatment.

Authors:  Mio Akiyama; Taro Mawatari; Yasuharu Nakashima; Hisaaki Miyahara; Hisakata Yamada; Ken Okazaki; Jun-ichi Fukushi; Masakazu Kondo; Junji Kishimoto; Chinami Hashimura; Yukihide Iwamoto
Journal:  Clin Rheumatol       Date:  2015-08-21       Impact factor: 2.980

6.  Relation of epicardial fat to central aortic pressure and left ventricular diastolic function in patients with known or suspected coronary artery disease.

Authors:  Kenta Hachiya; Hidekatsu Fukuta; Kazuaki Wakami; Toshihiko Goto; Tomomitsu Tani; Nobuyuki Ohte
Journal:  Int J Cardiovasc Imaging       Date:  2014-06-19       Impact factor: 2.357

7.  Pitavastatin: finding its place in therapy.

Authors:  Leiv Ose
Journal:  Ther Adv Chronic Dis       Date:  2011-03       Impact factor: 5.091

8.  A novel gene regulator, pyrrole-imidazole polyamide targeting ABCA1 gene increases cholesterol efflux from macrophages and plasma HDL concentration.

Authors:  Akiko Tsunemi; Takahiro Ueno; Noboru Fukuda; Takayoshi Watanabe; Kazunobu Tahira; Akira Haketa; Yoshinari Hatanaka; Sho Tanaka; Taro Matsumoto; Yoshiaki Matsumoto; Hiroki Nagase; Masayoshi Soma
Journal:  J Mol Med (Berl)       Date:  2014-01-25       Impact factor: 4.599

Review 9.  Cross-sectional survey to assess the status of lipid management in high-risk patients with dyslipidemia: clinical impact of combination therapy with ezetimibe.

Authors:  Tamio Teramoto; Atsunori Kashiwagi; Shun Ishibashi; Hiroyuki Daida
Journal:  Curr Ther Res Clin Exp       Date:  2012-02

Review 10.  Critical appraisal of the role of pitavastatin in treating dyslipidemias and achieving lipid goals.

Authors:  Yasushi Saito
Journal:  Vasc Health Risk Manag       Date:  2009-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.